Glaucoma occurs due to optic nerve damage. A common treatment is prescription eye drops. Although eye drops do not cure or reverse vision loss, they can help prevent optic nerve damage. Glaucoma ...

Developed by Glaukos, the iDose TR (travoprost intraocular implant) 75 mcg is a new, FDA-approved treatment that is designed ...

The damage caused by glaucoma can't be reversed. But treatment and regular checkups can help slow or prevent vision loss, especially if you catch the disease in its early stages. Glaucoma is treated ...

You may notice vision loss and changing glaucoma symptoms if your prescribed medicated eye drops stop working. Your doctor can help test your visual field and determine if you need different drops or ...

CHICAGO -- Upfront laser trabeculoplasty significantly slowed glaucoma progression and vision loss as compared with eye drops, long-term follow-up from a large randomized trial showed. After 6 years ...

SHREVEPORT, La. — Glaucoma is the second leading cause of blindness. And most of the time, it has no symptoms. Dr. Chris Shelby of the WK Eye Institute explains how glaucoma is treated: “Because ...

The CDC reports that over three million Americans have glaucoma. The number may reach 6.3 million by 2050 as the aging population grows. Glaucoma is affecting so many lives, so it’s important to know ...

Glaucoma affects tens of millions of individuals across the globe. According to the World Glaucoma Association, roughly 112 million people are likely to have glaucoma in 2040, which would mark an ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Dry eye prevalence based on Ocular Surface Disease Index ...

Please provide your email address to receive an email when new articles are posted on . Interventional procedures with eye drops as an adjunct are slowly becoming the foundational therapy for glaucoma ...

Oct 23 (Reuters) - This is an excerpt of the Health Rounds newsletter, where we present latest medical studies on Tuesdays and Thursdays. To receive it in your inbox for free sign up here, opens new ...

GENEVA--(BUSINESS WIRE)-- Alcon (SIX/NYSE: ALC), the global leader in eye care, dedicated to helping people see brilliantly, announced today the full U.S. commercial availability of Voyager™ DSLT, the ...